HYPERFINE INC CLASS A (HYPR)
Health Care · medical diagnostics / medical devices · NASDAQ
Hyperfine has redefined brain imaging with the first FDA-cleared, AI-powered portable MRI system designed to make brain scans accessible at the point of care.
What HYPERFINE INC CLASS A does
Hyperfine is a health technology company that produces the Swoop® Portable MR Imaging® System, an FDA-cleared, AI-powered portable ultra-low-field MRI scanner. The system is designed to provide accessible, affordable, and timely brain imaging in various care settings, including ICUs, emergency departments, and clinics, without the infrastructure requirements of conventional MRI.
Recent developments
Hyperfine reported preliminary Q3 2026 revenue of approximately $6.0 million, representing 53% sequential growth, and reaffirmed its full-year 2026 revenue guidance of $20–22 million. The company noted expanding adoption across hospital sites of care, office-based settings, and international markets for its Model 2 Swoop system.
From HYPERFINE INC CLASS A's filing of 2026-10-08.
Themes: point-of-care diagnostics, portable MRI, AI medical imaging, neurological care, brain health
Fundamentals
- Price$0.9401 as of 2026-10-08 close
- Market cap$100M as of 2026-08-03 (share count; price 2026-10-08)
- 1-year return-55.0% 2025-10-08 close $2.09 → 2026-10-08 close $0.9401
- P/En/a negative earnings
- Net margin-262.3% FY2025, SEC XBRL
- Gross margin+49.8% FY2025, SEC XBRL
- ROE-86.8% FY2025, SEC XBRL
- Debt / equity0.38 as of 2026-09-03
- Revenue growth (YoY)+30.7% as of 2026-09-03
- Revenue CAGR (3y)+25.8% SEC XBRL
- Beta1.75 as of 2026-09-03
- Last reported earnings2026-10-08 SEC EDGAR Form 8-K (Item 2.02)
How HYPR compares in its sector
- net profit marginbottom 25% 430 covered Health Care peers, as of 2026-09-03
- operating marginbottom 25% 417 covered Health Care peers, as of 2026-09-03
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-03
- return on equitybottom 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How HYPERFINE INC CLASS A looks technically
HYPERFINE INC CLASS A (HYPR) is trading 17.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 40 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 35, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day high, its first since 2026-08-11, pushing above its recent trading range. It is 57.7% below its highest point of the past year. Trading volume is running unusually high — about 21.0× its 30-day average, a sign of heightened interest.
Trend
8
| Distance from the 200-day | it is trading 17.7% below its 200-day average, the long-term trend line — a long-term downtrend | -17.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $0.8623 | $0.8623 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $1.14 | $1.14 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 17 calendar days ago — the swings before that are what the structure reading is measured on | 17 sessions |
| Wave structure | its recent swings can be read as a completed five-part downward sequence — the pattern Elliott-wave chartists call an impulse — which on that reading would now be due a pullback rather than more of the same; the labelling fails if price closes below 0.754. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible five-wave downward sequence, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 40 trading days ago — a "death cross", a bearish long-term signal | 40 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 35, with buyers in control | 34.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 65, neither overbought (above 70) nor oversold (below 30) | 64.8 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($0.754 to $0.99) — its "stochastic" reading is 79 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 78.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 50 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $2.22 | $2.22 |
|---|---|---|
| From the 52-week high | it is 57.7% below its 52-week high (its highest price of the past year) | -57.6% |
| Above the 52-week low | it is 24.7% above its 52-week low (its lowest price of the past year) | +24.7% |
| Below the 52-week high | it is 57.7% below its highest point of the past year | 57.6% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-08-11, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it made a new 55-day low about 16 trading days ago | 16 sessions |
| All-time high | its highest closing price on record is $11.99 (set on 2021-12-27) | $11.99 |
| Given back of the 52-week move | over the past year its closes ranged ($0.773 to $2.20), and it has recovered only a small part of its fall from last year’s high — 12% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $1.65 to $1.70. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 11.7% |
| From the all-time high | it is 92.2% below its all-time high | -92.2% |
| Nearest price level | it is trading 2.9% above a support level at $0.9133 — a price it turned at three times since 2025-01-21, most recently on 2026-07-17. Since 2024-10-08 it has 7 such levels below the current price and 7 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -2.9% |
| All-time low | its lowest closing price on record is $0.5327 (set on 2025-05-23) | $0.5327 |
| Above the all-time low | it is 76.5% above its all-time low | +76.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 34th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.0623 between its high and its low — about 6.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.0623 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $0.73 and $0.91 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $0.73 – $0.82 – $0.91 |
| Typical daily range (% of price) | its price moves about 6.6% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.6% |
| Stretch from the 200-day average | it is trading 3.3 daily ranges below its 200-day average price (17.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 21.0× its 30-day average, a sign of heightened interest | 20.98× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bearish engulfing | 3 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 3 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 16.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +16.6% |
|---|---|---|
| Gap filled | a 16.6% gap up opened on 2026-10-08 has been "filled" today — price traded back through the level the gap left behind, and it closed again during the very session that opened it | today |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 13.3 percentage points (the stock gained 14.4% while the market gained 1.0%) | +13.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 19.5 percentage points (the stock lost 15.7% while the market gained 3.8%) | -19.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 35.0 percentage points (the stock lost 17.5% while the market gained 17.5%) | -35.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 70.0 percentage points (the stock lost 55.0% while the market gained 15.0%) | -70.0% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive, a strong uptrend, with buyers in control — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 37.6% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 23% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $1.22 — a volume-weighted average of daily closes over 188 sessions, not a true tick-by-tick VWAP. | -22.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% above the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $0.8842 — a volume-weighted average of daily closes over 45 sessions, not a true tick-by-tick VWAP. | +6.3% |
Price levels it has turned at before
HYPR last closed at $0.9401 on 2026-10-08. Since 2024-10-08 it has turned at 7 prices below its last close and 7 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $0.9133 | Support | 2.9% below the last close | turned there three times · 2025-01-21 to 2026-07-17 |
| $0.8745 | Support | 7.0% below the last close | turned there twice · 2025-12-31 to 2026-07-29 |
| $1.03 | Resistance | 9.5% above the last close | turned there six times · 2024-11-25 to 2026-03-30 |
| $0.8503 | Support | 9.6% below the last close | turned there three times · 2024-12-18 to 2025-12-03 |
| $1.05 | Resistance | 12.0% above the last close | turned there three times · 2024-10-21 to 2026-08-04 |
| $1.10 | Resistance | 17.1% above the last close | turned there twice · 2025-01-03 to 2025-12-05 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $0.754.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 9 trading days, since 2026-09-28.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · Unusually heavy trading volume · Broke out to a new 20-day high · Broke out to a new 20-day high on heavy volume · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low · volume and relative volume
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$2.03 range $1.60 – $2.50; median $2.00
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HYPR
- Consensus EPS estimate-$0.08 next reporting period, as of 2026-10-09
- Estimate change, 30 days$0.00 from -$0.08, on 2026-09-04, 35-day window
- Readings revised upward0% of 6 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["History of losses and potential need for additional capital to fund operations","Dependency on the successful market adoption of the Swoop® system and evolving AI-powered software","Strict and evolving regulatory requirements (FDA/CE Mark) for medical devices and software updates"]
What changed in the latest 10-Q
AI-assisted comparison of HYPR's 10-Q filed 2026-05-12 against the prior one filed 2025-11-13.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing references 2025 Annual Report on Form 10-K (filed 2026-05-12), older filing references 2024 Annual Report on Form 10-K (filed 2025-11-13)
- Newer filing covers three months ended March 31, 2026 and 2025; older filing covers three and nine months ended September 30, 2025 and 2024
- Newer filing describes Swoop system as producing images at 'significantly lower magnetic field strength' vs. older filing's 'lower magnetic field strength'
- Newer filing specifies 'iPad-based interface' for operation; older filing references 'easy-to-use interface' without specifying iPad
- Newer filing states system 'does not require specialized MRI technicians to operate safely'; older filing states it 'does not require any special facilities accommodations nor specialized personnel to operate safely'
- Newer filing includes reference to 'Optive AI TM' as a specific form of AI in denoising and reconstruction pipeline with trademark notation
- Newer filing explicitly names 'Optive AI TM' models as proprietary and validated by expert radiologists
- Newer filing states 'eleven generations of software since our initial clearance'; older filing states 'ten generations of software since our initial clearance'
- Newer filing adds language about 'continuously investing in improving our AI-powered image quality and leveraging each imaging-focused software release to further improve the Swoop® system performance and clinical utility'; older filing omits 'and clinical utility'
- Newer filing describes tenth-generation software as producing images 'with greater clarity, uniformity and sharper anatomical detail'; older filing states 'and the result is brain images with greater clarity, uniformity and sharper anatomical detail'
- Newer filing states next-generation system 'incorporates innovations specifically engineered'; older filing states it 'features innovations specifically engineered'
- Newer filing text cuts off at 'In December 2025' suggesting additional content; older filing includes discussion of CE Mark and UKCA Mark approvals in October 2024 and February 2025
- Removed:
- Older filing includes references to Risk Factors sections in 2024 Form 10-K and Quarterly Reports for quarters ended March 31, 2025 and June 30, 2025; newer filing only references 2025 Form 10-K
- Older filing references 'installed base' language; newer filing uses 'installed base' in similar context but with different surrounding phrasing
- Older filing discusses marketing authorization outside United States including CE Mark and UKCA Mark approvals in October 2024 and February 2025; this content is cut off in newer filing
- Reworded:
- Older: 'enabling a highly differentiated experience for patients' changed to newer: 'enabling a highly differentiated patient-friendly experience'
- Older: 'favorable economics for hospital administrators' changed to newer: 'favorable economics for healthcare administrators'
- Older: 'intensive care units, clinics, emergency departments or physicians' offices' changed to newer: 'intensive care units, emergency departments, procedural rooms, clinics or physicians' offices' (addition of 'procedural rooms')
- Older: 'specialized operators' changed to newer: 'specialized technicians'
- Older: 'address the limitations of conventional imaging technologies' changed to newer: 'address the limitations of conventional MRI technologies'
- Older: 'accessible nearly anytime and anywhere' changed to newer: 'accessible nearly anywhere'
- Older: 'has the potential to offer clinical and economic benefits' changed to newer: 'has potential clinical and economic benefits'
- Older: 'a form of AI in the reconstruction pipeline of T1, T2, diffusion-weighted Imaging, and fluid-attenuated inversion recovery sequences' changed to newer: 'Optive AI TM, a form of AI in the denoising and reconstruction pipeline of the sequences'
- Older: 'The algorithms are designed to improve' changed to newer: 'Our proprietary Optive AI TM models are designed to improve'
- Older: 'The images created with these algorithms were validated by expert radiologists' changed to newer: 'The Optive AI TM models are validated by expert radiologists'
- Older: 'install base continues to expand' changed to newer: 'installed base continues to expand globally'
- Older: 'further improve the Swoop® system performance' changed to newer: 'further improve the Swoop® system performance and clinical utility'
- Older: 'A very important milestone for us was obtaining' changed to newer: 'Obtaining...was a very important milestone for us'
- Notes:
- The newer filing text appears truncated at 'In December 2025' making complete comparison of subsequent sections impossible
- Both filings discuss the same product and basic business model but cover different fiscal periods (Q1 2026 vs. Q3 2025)
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 2 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 2 sells ($12545) — 2 selling insiders
- Last 180 days · read to 2026-10-040 buys · 4 sells ($32500) — 2 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-24. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HYPR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding HYPR as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 6,678,570
- Reported value $9,016,070
reported quarterly holdings change (2026-03-31 → 2026-06-30): 1 new, 4 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about HYPR's institutional holders → See what each manager we track holds →
Short interest (FINRA)
HYPR had 4,236,754 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for HYPR because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 4,236,754
- Prior settlement (shares) 3,649,331
- Reported change 16.1%
- Days to cover (reported) 11.25
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- GE Healthcare (GEHC)
- Siemens Healthineers (SMMNY)
- Philips (PHG)
- Canon Medical Systems
- Fujifilm Healthcare
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HYPR vs…
Frequently asked questions
What does HYPERFINE INC CLASS A (HYPR) do?
Hyperfine is a health technology company that produces the Swoop® Portable MR Imaging® System, an FDA-cleared, AI-powered portable ultra-low-field MRI scanner. The system is designed to provide accessible, affordable, and timely brain imaging in various care settings, including ICUs, emergency departments, and clinics, without the infrastructure requirements of conventional MRI.
What sector is HYPERFINE INC CLASS A (HYPR) in?
HYPERFINE INC CLASS A (HYPR) is classified in the Health Care sector. Its industry is medical diagnostics / medical devices. It trades on NASDAQ.
Who are HYPERFINE INC CLASS A's (HYPR) competitors?
Notable peers of HYPERFINE INC CLASS A (HYPR) include GE Healthcare, Siemens Healthineers, Philips, Canon Medical Systems and Fujifilm Healthcare. This peer set is informational only — not financial advice.
Is HYPERFINE INC CLASS A (HYPR) overbought or oversold right now?
HYPERFINE INC CLASS A (HYPR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 65, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HYPR come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.